- CA$11.89m
- CA$11.61m
- CA$3.42m
- 66
- 92
- 40
- 73
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2 | 2.23 | 2.66 | 3.04 | 3.42 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.359 | 0.294 | 0.275 | 0.803 | 0.448 |
Operating Profit | 1.64 | 1.93 | 2.39 | 2.24 | 2.97 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.67 | 1.93 | 2.39 | 2.24 | 2.97 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.67 | 1.93 | 5.4 | 1.51 | 2 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.67 | 1.93 | 5.4 | 1.51 | 2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.67 | 1.93 | 5.4 | 1.51 | 2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.058 | 0.067 | 0.189 | 0.053 | 0.07 |
Dividends per Share |